Hepatic steatosis and liver stiffness in patients with gout: a controlled cross-sectional elastography study

dc.contributor.authorCüre, Osman
dc.contributor.authorAvcı, Uğur
dc.contributor.authorKılıç, Emre Emir
dc.contributor.authorYiğit, Ertuğrul
dc.date.accessioned2026-11-20T07:32:19Z
dc.date.issued2026
dc.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractBackground/Objective: Gout shares cardiometabolic risk factors with metabolic dysfunction–associated steatotic liver disease (MASLD). We aimed to compare elastography-defined hepatic steatosis and liver stiffness between patients with gout and metabolically stringent controls, and to identify independent determinants of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM). Methods: In this single-center cross-sectional study (April 2024–January 2026), 201 adults with gout and 80 controls free of hypertension, diabetes mellitus, chronic kidney disease, and coronary artery disease underwent vibration-controlled transient elastography (FibroScan®). Multivariable linear and logistic regression models identified independent predictors of CAP, LSM, and binary elastographic outcomes. Results: Patients with gout had significantly higher CAP (279 vs. 251.5 dB/m; p < 0.001) and LSM (6.1 vs. 5.1 kPa; p < 0.001). In unadjusted analyses, the odds of hepatic steatosis (CAP ≥ 238 dB/m; OR 2.42, 95% CI 1.40–4.20; p = 0.001) and of increased liver stiffness (LSM ≥ 7.0 kPa; OR 2.46, 95% CI 1.27–4.78; p = 0.007) were higher in the gout group, and LSM ≥ 9.6 kPa was more frequent (12.9% vs. 1.3%; p = 0.001). On multivariable analysis, BMI and ALT were the principal determinants of CAP, whereas BMI and age independently predicted continuous LSM. Gout status was not independently associated with CAP, continuous LSM, hepatic steatosis, or increased liver stiffness (adjusted OR 1.83, 95% CI 0.84–4.01; p = 0.131). Serum uric acid and disease activity measures were not associated with any elastographic outcome. Conclusion: Patients with gout exhibit a substantially higher burden of elastography-defined hepatic steatosis and increased liver stiffness than metabolically stringent controls. This excess was accounted for by adiposity and age rather than by gout status or urate levels, suggesting that non-invasive liver assessment in gout should be guided by cardiometabolic risk profile rather than by the diagnosis of gout itself. (Table presented.)
dc.identifier.citationCure, O., Avci, U., Kilic, E. E., & Yigit, E. (2026). Hepatic steatosis and liver stiffness in patients with gout: a controlled cross-sectional elastography study. Clinical rheumatology, 45(12), 7533–7546. https://doi.org/10.1007/s10067-026-08463-7
dc.identifier.doi10.1007/s10067-026-08463-7
dc.identifier.endpage7546
dc.identifier.issn0770-3198
dc.identifier.issue12
dc.identifier.scopus2-s2.0-105053850006
dc.identifier.scopusqualityQ2
dc.identifier.startpage7533
dc.identifier.urihttps://doi.org/10.1007/s10067-026-08463-7
dc.identifier.urihttps://hdl.handle.net/11436/13847
dc.identifier.volume45
dc.indekslendigikaynakScopus
dc.institutionauthorCüre, Osman
dc.institutionauthorAvcı, Uğur
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofClinical Rheumatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGout
dc.subjectHepatic steatosis
dc.subjectLiver stiffness
dc.subjectMASLD
dc.subjectTransient elastography
dc.subjectUric acid
dc.titleHepatic steatosis and liver stiffness in patients with gout: a controlled cross-sectional elastography study
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
cüre-2026 (4).pdf
Boyut:
1.35 MB
Biçim:
Adobe Portable Document Format

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: